<strong>Background.</strong> The incidence of benign prostatic hyperplasia (BPH) has grown by almost 35 % over the last five years with an incidence rate of 4438,2 per 100 000 of the respective population (147 677 total patients) in Ukrainian men beyond working age in 2007 [3].<br /><strong>Objective.</strong> The aim of the study was to assess the efficacy of TUMT in men where BPH was complicated by AUR and severe comorbidities.<br /><strong>Method.</strong> TUMT was performed using the domestically produced equipment ‘ALMGP-01’ at the frequency of 1300 Hz, rectal temperature of 42.5 °C, and urethral temperature of 44.5 °C. The average session duration is 46-55 minutes.<br /><strong>Results and Discussion.</strong> Subjective self-assessment: no effect of the procedure was detected (urination not restored) in 9 patients (11.11 %); poor current status with prior temporary improvement (6-9 months of independent urination with repeated AUR) in 14 patients (17.28 %); satisfactory current status with occasional dysuric episodes (however better than pre-TUMT status) in 40 patients (49.38 %). Eight patients (22.22 %) have assessed their status as ‘good’ and ‘excellent’; one patient noted substantial improvement compared to pre-procedure status. The nine patients with lack of success of restoring physiological urination had the following peculiarities: intra-vesical growth of BPH and prostatic volume over 85 cm3 in majority of these patients.<br /><strong>Conclusions.</strong> Taking into consideration the minimally invasive nature, favourable tolerability and absence of adverse effects, TUMT can be considered a method of choice in patients with BPH-triggered AUR and contraindications to major surgical treatments and general anaesthesia. Remote outcomes of TUMT may be evaluated as satisfactory, with good effects in 71.62% patients. However in prostatic volumes exceeding 85 cm<sup>3</sup> and pronounced intravesical pattern of BPH growth the efficcacy of TUMT is arguable.<br /><br /><strong>KEY WORDS:</strong> benign prostatic hyperplasia, acute urinary retention, transurethral microwave hermotherapy.
Advances in the medical management of benign prostatic hyperplasia
